These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 1973870
1. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist. Pan S, Liao CH. Am J Gastroenterol; 1990 Aug; 85(8):949-52. PubMed ID: 1973870 [Abstract] [Full Text] [Related]
2. Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine. Pan SA, Liao CH, Lien GS, Chen SH. Gastroenterology; 1991 Nov; 101(5):1187-91. PubMed ID: 1936788 [Abstract] [Full Text] [Related]
3. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing. Khasawneh SM, Affarah HB. Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576 [Abstract] [Full Text] [Related]
4. Histological maturity of healed duodenal ulcer and ulcer recurrence after treatment with omeprazole or cimetidine. Pan S, Liao CH, Lien GS, Chen SH. J Gastroenterol Hepatol; 1994 Sep; 9 Suppl 1():S84-7. PubMed ID: 7881026 [Abstract] [Full Text] [Related]
5. [H2 blockers in the treatment of bleeding gastroduodenal ulcers]. Nikiforov PA, Bazarova MA, Nikitina SA, Osin VL, Shugurov VA. Khirurgiia (Mosk); 2001 Sep; (10):49-50. PubMed ID: 11763821 [No Abstract] [Full Text] [Related]
6. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group. Cherner JA, Cloud ML, Offen WW, Latz JE. Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086 [Abstract] [Full Text] [Related]
7. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany]. Simon B, Dammann HG, Jakob G, Miederer SE, Müller P, Ottenjann R, Paul F, Scholten T, Schütz E, Seifert E. Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859 [Abstract] [Full Text] [Related]
8. [Sulglycotide combined with H2-antagonists in the prevention of duodenal ulcer recurrence. Multicenter study]. Ciaco A, Papi C, Capurso L. Minerva Gastroenterol Dietol; 1992 Feb; 38(3):153-9. PubMed ID: 1363719 [Abstract] [Full Text] [Related]
9. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy]. Baglioni A, Barbara L, Bianchi-Porro G, Blasi A, Canelli B, Cheli R, Dal Monte R, Dammann HG, Francavilla A, Hentschel E. Z Gastroenterol; 1985 Dec; 23(12):665-9. PubMed ID: 2868581 [Abstract] [Full Text] [Related]
10. [Prevention of the recurrence of duodenal ulcer with famotidine. Report of experiences with long-term therapy in an open clinical study]. Judmaier G. Wien Med Wochenschr; 1992 Dec; 142(18):406-7. PubMed ID: 1475985 [Abstract] [Full Text] [Related]
11. [Early evening and late evening administration of roxatidine acetate in therapy of duodenal ulcer]. Bosseckert H, Ernst R, Kriech W, Schunter C. Med Klin (Munich); 1993 Nov 15; 88(11):637-41. PubMed ID: 7905185 [Abstract] [Full Text] [Related]
12. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists. Chelvam P, Wong EC. J Gastroenterol Hepatol; 1989 Nov 15; 4 Suppl 2():75-81. PubMed ID: 2577478 [Abstract] [Full Text] [Related]
13. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Korman MG, Hansky J, Eaves ER, Schmidt GT. Gastroenterology; 1983 Oct 15; 85(4):871-4. PubMed ID: 6136450 [Abstract] [Full Text] [Related]
14. Deformity of duodenal bulb, gastric metaplasia of duodenal regenerating mucosa and recurrence of duodenal ulcer: a correlated study. Chang CC, Pan S, Lien GS, Liao CH, Chen SH, Cheng YS. World J Gastroenterol; 2005 Mar 28; 11(12):1802-5. PubMed ID: 15793868 [Abstract] [Full Text] [Related]
15. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats. Sekiguchi H, Hamada K, Aijima H, Taga F, Uchida H, Nishino K. Arzneimittelforschung; 1993 Feb 28; 43(2):139-43. PubMed ID: 8096134 [Abstract] [Full Text] [Related]
16. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection. Freston JW. Am J Gastroenterol; 1987 Dec 28; 82(12):1242-9. PubMed ID: 2891294 [Abstract] [Full Text] [Related]
17. A comparative study of colloidal bismuth subcitrate and cimetidine on the healing and recurrence of duodenal ulcer. Vantrappen G, Schuurmans P, Rutgeerts P, Janssens J. Scand J Gastroenterol Suppl; 1982 Dec 28; 80():23-30. PubMed ID: 6761849 [Abstract] [Full Text] [Related]
18. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level. Ohsawa T, Hirata W, Higichi S. Int J Clin Pharmacol Res; 2002 Dec 28; 22(2):29-35. PubMed ID: 12503773 [Abstract] [Full Text] [Related]
19. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists. Chen PH, Wang TH, Wang CY, Chen CY, Cheng TC, Tsai YT, Siauw CP, Yang KC, Chen GH, Sung JL. J Int Med Res; 1989 Dec 28; 17 Suppl 1():25A-31A. PubMed ID: 2566541 [Abstract] [Full Text] [Related]
20. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients. Lezoche E, Vagni V, D'Alessandro MD, Mariani P, Carlei F, Lomanto D, Nardovino M, Martelli A, Speranza V. Drugs Exp Clin Res; 1987 Dec 28; 13(10):655-8. PubMed ID: 2892658 [Abstract] [Full Text] [Related] Page: [Next] [New Search]